Immunotherapy Drugs Market Share, Trends, Revenue, Competition, Growth Drivers, Challenges, CAGR Status and Business Opportunities Till 2033: SPER Market Research
Immunotherapy is a type of medical treatment that stimulates the immune system to attack diseases such as cancer. Immunotherapy drugs aim to improve or modify the immune system's response to aberrant cells. Immunotherapy is used to treat cancers like melanoma, non-small cell lung cancer (NSCLC), and head and neck squamous cell carcinoma. It particularly targets the PD-1 protein in immune cells, enabling them to kill cancer cells more effectively. Immunotherapy is used to treat certain types of lymphomas and leukaemia. It requires reprogramming a patient's T cells to express a Chimeric Antigen Receptor (CAR) that specifically targets cancer cells. As reported by SPER Market Research in the publication titled “Global Immunotherapy Drugs Market Size - By Drug Type, Therapy Area, and End User: Regional Outlook, Competitive Strategies, and Segment Forecast to 2033,” the global market for immunotherapy drugs is projected to reach USD 674.09 billion by 2033, growing at a compound ...